| $337M | ||
| $259M | ||
| $100M | ||
| $79M | ||
| $60M | ||
| $58M |
Buys | $0 | 0 | – |
Sells | $0 | 0 | – |
Titan Pharmaceuticals, Inc., a pharmaceutical company, develops therapeutics for the treatment of chronic diseases. It develops products based on ProNeura, a proprietary long-term drug delivery platform. The company offers Probuphine implant for the maintenance treatment of opioid use disorder in clinically stable patients in Canada and the European Union. It is also developing kappa opioid agonist peptide program (TP-2021) for use in combination with ProNeura technology for the treatment of chronic pruritus; nalmefene implant program for the prevention of opioid relapse following detoxification of patients suffering opioid use disorder; and other programs, including HIV preventative therapeutic and a contraceptive from a single ProNeura implant for women and adolescent girls. The company was incorporated in 1992 and is based in South San Francisco, California.
Over the last 12 months, insiders at Titan Pharmaceuticals, Inc. have bought $0 and sold $0 worth of Titan Pharmaceuticals, Inc. stock.
On average, over the past 5 years, insiders at Titan Pharmaceuticals, Inc. have bought $397,648 and sold $441,651 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 20,000 shares for transaction amount of $20,066 was made by Lazar David E. (Chief Executive Officer) on 2023‑01‑25.
| 2023-06-21 | Sale | Lazar David E. | Chief Executive Officer | 359,066 3.9347% | $1.23 | $441,651 | -49.33% | |
| 2023-01-25 | Lazar David E. | Chief Executive Officer | 20,000 0.1494% | $1.00 | $20,066 | -43.00% | ||
| 2023-01-24 | Lazar David E. | Chief Executive Officer | 37,500 0.2755% | $0.97 | $36,221 | -40.82% | ||
| 2022-07-06 | Activist Investing LLC | 744,294 5.613% | $0.99 | $739,010 | +3.33% | |||
| 2018-10-19 | Recli Federico Seghi | director | 200,000 0.3009% | $0.41 | $81,680 | -36.40% | ||
| 2018-09-24 | Recli Federico Seghi | director | 500,000 2.3618% | $0.23 | $113,800 | +9.85% | ||
| 2018-09-21 | Rubin Marc | Executive Chairman | 400,000 2.107% | $0.25 | $100,000 | +10.23% | ||
| 2018-09-21 | BHONSLE SUNIL | See Remarks | 300,000 1.5802% | $0.25 | $75,000 | +10.23% | ||
| 2018-09-21 | MCNAB JAMES R | director | 200,000 1.0535% | $0.25 | $50,000 | +10.23% | ||
| 2018-09-21 | Akers Joseph A | director | 200,000 1.0535% | $0.25 | $50,000 | +10.23% | ||
| 2018-09-21 | MACFARLANE M DAVID | director | 80,000 0.4214% | $0.25 | $20,000 | +10.23% | ||
| 2016-07-19 | Akers Joseph A | director | 5,000 0.023% | $4.68 | $23,400 | -13.54% | ||
| 2016-07-18 | BHONSLE SUNIL | President and CEO | 10,000 0.0474% | $4.96 | $49,550 | -15.82% | ||
| 2016-07-18 | Akers Joseph A | director | 8,000 0.0379% | $4.95 | $39,600 | -15.82% | ||
| 2016-05-31 | MCNAB JAMES R | director | 20,000 0.0975% | $7.03 | $140,600 | -36.70% | ||
| 2016-02-22 | BHONSLE SUNIL | President and CEO | 11,763 0.0596% | $3.56 | $41,817 | +42.86% | ||
| 2016-01-15 | BHONSLE SUNIL | President and CEO | 5,841 0.0255% | $2.72 | $15,888 | +61.29% | ||
| 2016-01-13 | MCNAB JAMES R | director | 16,363 0.0756% | $3.16 | $51,707 | +46.63% | ||
| 2016-01-11 | Rubin Marc | Executive Chairman | 5,000 0.027% | $3.25 | $16,250 | +66.67% | ||
| 2016-01-11 | BHONSLE SUNIL | President and CEO | 17,000 0.0898% | $3.18 | $54,060 | +66.67% |
| Activist Investing LLC | 3331402 364.3927% | $14.99M | 1 | 0 | +3.33% | |
| Recli Federico Seghi | director | 800845 87.5974% | $3.6M | 2 | 0 | |
| Rubin Marc | Executive Chairman | 556317 60.8506% | $2.5M | 9 | 0 | |
| BUCALO LOUIS R MD | President and CEO | 550000 60.1597% | $2.48M | 5 | 0 | |
| Kapp Joachim Friedrich | director | 546339 59.7592% | $2.46M | 12 | 5 | |
| BHONSLE SUNIL | See Remarks | 435578 47.644% | $1.96M | 23 | 0 | |
| MCNAB JAMES R | director | 300000 32.8144% | $1.35M | 3 | 0 | |
| Akers Joseph A | director | 213000 23.2982% | $958,500.00 | 3 | 0 | |
| FARRELL ROBERT EDWARD | Exec Vice President and CFO | 120580 13.1892% | $542,610.00 | 7 | 0 | |
| MACFARLANE M DAVID | director | 102275 11.187% | $460,237.50 | 1 | 0 | |
| HUCKEL HUBERT E MD | director | 62200 6.8035% | $279,900.00 | 1 | 1 | |
| HSU MICHAEL | director | 28117 3.0755% | $126,526.50 | 0 | 4 | |
| BAUER VICTOR J PHD | director | 8644 0.9455% | $38,898.00 | 0 | 1 | |
| ALLEN RICHARD C | Executive Vice President | 0 0% | $0 | 0 | 4 | |
| Lazar David E. | Chief Executive Officer | 0 0% | $0 | 2 | 1 |
$13,665,147 | 42 | -70.74% | $2.53M | |
$47,363 | 28 | -14.61% | $4.29M | |
$1,138,733 | 28 | -4.94% | $5.09M | |
$193,112 | 22 | -20.59% | $1.44M | |
$742,412 | 14 | -50.36% | $5.14M | |
$4,146,041 | 11 | -40.86% | $1.1M | |
$139,855 | 11 | -32.84% | $5.16M | |
$111,748 | 9 | -47.72% | $5.01M | |
$100,375 | 8 | -51.85% | $3.83M | |
$159,974 | 7 | -18.60% | $4.5M | |
$46,740 | 5 | -73.90% | $3.67M | |
$726,438 | 4 | -72.85% | $5.22M | |
$115,514 | 4 | -94.89% | $3.92M | |
$14,530 | 3 | 62.23% | $4.44M | |
$53,042 | 3 | -44.40% | $3.36M | |
$37,465 | 3 | -40.67% | $2.72M | |
$552,301 | 2 | -80.60% | $1.27M | |
$1,049,630 | 1 | -74.91% | $4.65M | |
Titan Pharmaceuticals, Inc. (TTNP) | $739,010 | 1 | 3.33% | $4.11M |
| Increased Positions | 5 | +33.33% | 12,057 | +417.34% |
| Decreased Positions | 2 | -13.33% | 238 | -8.24% |
| New Positions | 3 | New | 12,055 | New |
| Sold Out Positions | <1 | Sold Out | 165 | Sold Out |
| Total Postitions | 18 | +20% | 14,708 | +409.1% |
| Ubs Group Ag | $10.00 | 0.27% | 2,667 | -2,106 | -44.12% | 2024-12-31 |
| Mcf Advisors Llc | $1.00 | 0.02% | 165 | 0 | 0% | 2024-12-31 |
| Bank Of America Corp /De/ | $0 | <0.01% | 17 | 0 | 0% | 2024-12-31 |
| Group One Trading Llc | $0 | <0.01% | 12 | 0 | 0% | 2024-12-31 |
| Osaic Holdings, Inc. | $0 | <0.01% | 7 | -3 | -30% | 2024-12-31 |
| Blackrock, Inc. | $0 | <0.01% | 6 | +6 | New | 2025-03-31 |
| Morgan Stanley | $0 | 0% | 3 | <1 | -25% | 2024-12-31 |
| Global Wealth Strategies & Associates | $0 | 0% | 2 | 0 | 0% | 2025-03-31 |
| Caldwell Sutter Capital, Inc. | $0 | 0% | 1 | 0 | 0% | 2025-03-31 |
| Cape Investment Advisory, Inc. | $0 | 0% | 1 | 0 | 0% | 2024-12-31 |